Xencor | Ordinære Aksjekapital



Ordinary Share Capital Endring Dato
AbbVie USD 18M 0 2024-12
Alnylam Pharmaceuticals USD 1.3M 10K 2025-03
Amgen USD 33.58B 45M 2025-03
Arrowhead Research USD 218K 1000 2024-12
AstraZeneca USD 388M 0 2025-03
Biogen USD 100K 0 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
Cytokinetics USD 119K 1000 2025-03
GlaxoSmithKline GBP 1.35B 1000K 2025-03
J&J USD 3.12B 0 2025-03
MacroGenics USD 628K 1000 2024-12
Merck USD 1.79B 0 2025-03
Novartis USD 793M 0 2024-12
Pfizer USD 481M 1000K 2025-03
Regeneron Pharmaceuticals USD 0 102K 2025-03
Roche Holding CHF 107M 0 2024-06
Xencor USD 712K 9K 2025-03



Xencor Ordinære Aksjekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.